<DOC>
	<DOCNO>NCT02038634</DOCNO>
	<brief_summary>The investigator aim perform prospective study evaluate effectiveness blind corticosteroid injection US-guided injection treatment de Quervain 's disease . The result study used validate current injection protocol support incorporation ultrasonography treat disease .</brief_summary>
	<brief_title>Ultrasound-guided Injection DeQuervain 's</brief_title>
	<detailed_description>De Quervain 's disease stenosing tenosynovitis tendinitis abductor pollicis longus ( APL ) extensor pollicis brevis ( EPB ) tendon first dorsal compartment wrist . While prevalence de Quervain 's yet well-established , previous study show woman affect disease six time frequently men . Conservative treatment include splint corticosteroid injection , surgery option therapy fail . There previous study compare improvement rate patient treat splint alone , injection splinting , injection alone , found rate improvement 19 % , 57 % , 67 % , respectively . This confirm good result report previous study recommend corticosteroid injection clinician reliable treatment de Quervain 's disease . A seminal study perform correlate accuracy corticosteroid injection pain relief include X-ray dye injection . The result study suggest strong correlation accurate injection first dorsal compartment pain relief . Since , use ultrasonography ( US ) guide steroid injection suggest possible clinical practice , little research do technique . A 2009 study report 93.75 % rate significant pain relief use US-guided injection , control group compare result . The current standard practice steroid injection de Quervain 's patient blind injection without image guidance . To investigator knowledge , study compare accuracy clinical outcome blind injection US-guided injection . The investigator hypothesize US-guided injection result great pain relief patient blind injection . This intend prospective study . Patients contact Dr. 's Grindel Daley standard clinical evaluation , include palpation first extensor compartment application Finkelstein test . Those diagnosed de Quervain 's disease fit inclusion criterion receive detailed verbal description study one doctor , attain write , informed consent willing participant . Dr. 's Grindel Daley administer either blind US-guided injection . The patient return follow-up appointment 6-8 week 12-16 week undergo another physical exam determine pain relief . A phone call follow-up also place one year injection order determine long-term effectiveness . Once 20 study subject group ( 40 total ) enrol complete treatment , data undergo statistical analysis . This study pose minimal physical risk study subject , US-guided injection show well pain relief patient current standard treatment ( blind injection ) . In summary , investigator aim perform prospective study evaluate effectiveness blind corticosteroid injection US-guided injection treatment de Quervain 's disease . The result study used validate current injection protocol support incorporation ultrasonography treat disease .</detailed_description>
	<mesh_term>Tenosynovitis</mesh_term>
	<mesh_term>Betamethasone benzoate</mesh_term>
	<mesh_term>Betamethasone-17,21-dipropionate</mesh_term>
	<mesh_term>Betamethasone</mesh_term>
	<mesh_term>Betamethasone Valerate</mesh_term>
	<mesh_term>Betamethasone sodium phosphate</mesh_term>
	<criteria>Pain palpation 1st dorsal compartment wrist positive Finkelstein 's Test Patients evidence osteoarthritis degeneration wrist .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>wrist</keyword>
	<keyword>tendonitis</keyword>
	<keyword>dequervain 's</keyword>
	<keyword>tenosynovitis</keyword>
</DOC>